215 related articles for article (PubMed ID: 38559078)
1. Integrated
Agrawal P; Chen S; de Pablos A; Jame-Chenarboo F; Miera Saenz de Vega E; Darvishian F; Osman I; Lujambio A; Mahal LK; Hernando E
bioRxiv; 2024 Mar; ():. PubMed ID: 38559078
[TBL] [Abstract][Full Text] [Related]
2. Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.
Zhang N; Lin S; Cui W; Newman PJ
Blood Adv; 2022 Jul; 6(13):3945-3955. PubMed ID: 35507766
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD; Fan TC; Hung JT; Yeo HL; Wang SH; Kuo CW; Khoo KH; Pai LM; Yu J; Yu AL
Cancer Immunol Res; 2021 Jan; 9(1):113-122. PubMed ID: 33177111
[TBL] [Abstract][Full Text] [Related]
4. "Aberrant sialylation plays a significant role in oral squamous cell carcinoma progression".
Mehta KA; Patel KA; Pandya SJ; Patel PS
J Oral Pathol Med; 2020 Mar; 49(3):253-259. PubMed ID: 31747460
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of the major brain gangliosides GD1a and GT1b.
Sturgill ER; Aoki K; Lopez PH; Colacurcio D; Vajn K; Lorenzini I; Majić S; Yang WH; Heffer M; Tiemeyer M; Marth JD; Schnaar RL
Glycobiology; 2012 Oct; 22(10):1289-301. PubMed ID: 22735313
[TBL] [Abstract][Full Text] [Related]
6.
Deschuyter M; Leger DY; Verboom A; Chaunavel A; Maftah A; Petit JM
Am J Cancer Res; 2022; 12(1):280-302. PubMed ID: 35141018
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of vasorin by ST3Gal1 facilitates TGF-β1-mediated tumor angiogenesis and progression.
Yeo HL; Fan TC; Lin RJ; Yu JC; Liao GS; Chen ES; Ho MY; Lin WD; Chen K; Chen CH; Hung JT; Wu JC; Chang NC; Chang MD; Yu J; Yu AL
Int J Cancer; 2019 Apr; 144(8):1996-2007. PubMed ID: 30252131
[TBL] [Abstract][Full Text] [Related]
8. Alterations in Sialylation Patterns are Significantly Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia.
Patel KD; De M; Jethva DD; Rathod BS; Patel PS
Arch Med Res; 2022 Jan; 53(1):51-58. PubMed ID: 34275666
[TBL] [Abstract][Full Text] [Related]
9. Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans.
Giovannone N; Antonopoulos A; Liang J; Geddes Sweeney J; Kudelka MR; King SL; Lee GS; Cummings RD; Dell A; Barthel SR; Widlund HR; Haslam SM; Dimitroff CJ
Front Immunol; 2018; 9():2857. PubMed ID: 30619255
[TBL] [Abstract][Full Text] [Related]
10. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
[TBL] [Abstract][Full Text] [Related]
11. The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice.
Xi D; Hofmann L; Alter T; Einspanier R; Bereswill S; Heimesaat MM; Gölz G; Sharbati S
Gut Pathog; 2021 Jun; 13(1):42. PubMed ID: 34183045
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal feedback regulation of ST3GAL1 and GFRA1 signaling in breast cancer cells.
Fan TC; Yeo HL; Hsu HM; Yu JC; Ho MY; Lin WD; Chang NC; Yu J; Yu AL
Cancer Lett; 2018 Oct; 434():184-195. PubMed ID: 30040982
[TBL] [Abstract][Full Text] [Related]
13. Altered O-linked glycosylation in benign and malignant meningiomas.
Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
PeerJ; 2024; 12():e16785. PubMed ID: 38274327
[TBL] [Abstract][Full Text] [Related]
14. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis.
Chong YK; Sandanaraj E; Koh LW; Thangaveloo M; Tan MS; Koh GR; Toh TB; Lim GG; Holbrook JD; Kon OL; Nadarajah M; Ng I; Ng WH; Tan NS; Lim KL; Tang C; Ang BT
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26547933
[TBL] [Abstract][Full Text] [Related]
15. Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer.
Wu X; Zhao J; Ruan Y; Sun L; Xu C; Jiang H
Cell Death Dis; 2018 Oct; 9(11):1102. PubMed ID: 30375371
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors.
Alvarez MRS; Zhou Q; Grijaldo SJB; Lebrilla CB; Nacario RC; Heralde FM; Rabajante JF; Completo GC
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744954
[TBL] [Abstract][Full Text] [Related]
17. Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli.
Ortiz-Soto ME; Seibel J
PLoS One; 2016; 11(5):e0155410. PubMed ID: 27166796
[TBL] [Abstract][Full Text] [Related]
18. Mammalian sialyltransferases allow efficient Escherichia coli-based production of mucin-type O-glycoproteins but can also transfer Kdo.
Sim L; Thompson N; Geissner A; Withers SG; Wakarchuk WW
Glycobiology; 2022 Apr; 32(5):429-440. PubMed ID: 34939113
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid linkage-specific quantitative N-glycoproteomics using selective alkylamidation and multiplex TMT-labeling.
Yang H; Tian Z
Anal Chim Acta; 2022 Oct; 1230():340391. PubMed ID: 36192063
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance.
Lopez PH; Aja S; Aoki K; Seldin MM; Lei X; Ronnett GV; Wong GW; Schnaar RL
Glycobiology; 2017 Jan; 27(2):129-139. PubMed ID: 27683310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
